Exclusion criteria and generalizability in bipolar disorder treatment trials
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2018/03/01
-
Indian UGC (journal)
-
Refrences33
-
Citations12
-
Jessie J. Wong
-
Nev Jones
-
Christine Timko
-
Keith Humphreys
Cite
Wong, Jessie J., et al. “Exclusion Criteria and Generalizability in Bipolar Disorder Treatment Trials”. Contemporary Clinical Trials Communications, vol. 9, 2018, pp. 130-4, https://doi.org/10.1016/j.conctc.2018.01.009.
Wong, J. J., Jones, N., Timko, C., & Humphreys, K. (2018). Exclusion criteria and generalizability in bipolar disorder treatment trials. Contemporary Clinical Trials Communications, 9, 130-134. https://doi.org/10.1016/j.conctc.2018.01.009
Wong JJ, Jones N, Timko C, Humphreys K. Exclusion criteria and generalizability in bipolar disorder treatment trials. Contemporary Clinical Trials Communications. 2018;9:130-4.
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Exclusion criteria in treatment research on alcohol, tobacco and illicit drug use disorders: A review and critical analysis | Drug and Alcohol Review |
| 19 | 2016 |
| The Psychiatric Inclusion and Exclusion Criteria in Placebo-Controlled Monotherapy Trials of Bipolar Depression: An Analysis of Studies of the Past 20 Years | CNS Drugs |
| 7 | 2016 |
| Considering eligibility for studies of deep brain stimulation for treatment-resistant depression: insights from a clinical trial in unipolar and bipolar depression | The Journal of ECT |
| 2015 | |
| Should an assessment of Axis I comorbidity be included in the initial diagnostic assessment of mood disorders? Role of QIDS-16-SR total score in predicting number of Axis I comorbidity | Journal of Affective Disorders |
| 27 | 2013 |
| Generalizability of clinical trial results for bipolar disorder to community samples: findings from the national epidemiologic survey on alcohol and related conditions | 2013 |
Refrences Analysis
The category
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system: Psychiatry 17
is the most frequently represented among the references in this article. It primarily includes studies from CNS Drugs The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin | Med |
| 2 | 2024 |
A toolkit for capturing a representative and equitable sample in health research | Nature Medicine |
| 1 | 2023 |
A literature review of the impact of exclusion criteria on generalizability of clinical trial findings to patients with chronic pain | PAIN Reports |
| 1 | 2022 |
Poor quality of life and functioning in euthymic mood disorders | Anatolian Current Medical Journal | 2022 | ||
| Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations | Drugs |
| 42 | 2021 |
Citations Analysis
The category
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system: Psychiatry 3
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Personalized Pharmacotherapy for Bipolar Disorder: How to Tailor Findings From Randomized Trials to Individual Patient-Level Outcomes and was published in 2019. The most recent citation comes from a 2024 study titled Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin. This article reached its peak citation in 2020, with 4 citations. It has been cited in 11 different journals, 18% of which are open access. Among related journals, the The American Journal of Bioethics cited this research the most, with 2 citations. The chart below illustrates the annual citation trends for this article.